All In Biotech

Free tool

FAERS Monitor: Crysvita

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761068 or its brand name (Crysvita, Burosumab-Twza). Reports on generic versions are filed under their own applications.

Reports

6,487

Serious

1,394

21% of reports

Hospitalization

481

Death reported

43

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • inappropriate schedule of product administration719
  • product dose omission issue677
  • blood phosphorus decreased584
  • pain408
  • arthralgia385
  • pain in extremity364
  • restless legs syndrome284
  • headache282
  • fatigue260
  • incorrect dose administered258
  • injection site pain246
  • bone pain216
  • back pain194
  • contraindicated product administered192
  • pyrexia185

Reports by year received

View as table
YearReports
2018117
2019801
20201,134
20211,266
20221,336
2023417
2024454
2025493
2026469

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,672 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood phosphorus decreasedSignal584616.2566.0300,984
restless legs syndromeSignal28451.445.913,786
contraindicated product administeredSignal19220.718.03,560
inappropriate schedule of product administrationSignal71913.012.17,977
bone painSignal21612.010.52,164
product dose omission issueSignal6777.57.03,839
pain in extremitySignal3644.03.6830
incorrect dose administeredSignal2583.73.3503
arthralgiaSignal3853.02.7523
back painSignal1942.72.4210
injection site painSignal2462.62.3244
painSignal4082.22.0259
pyrexia1851.71.558
headache2821.51.341
fatigue2601.11.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.